期刊文献+

新型喹唑啉类化合物的合成研究 被引量:1

Synthesis of Novel Quinazoline Compounds
下载PDF
导出
摘要 以2-氨基-4-甲氧基-3-(3-氯丙氧基)苯甲酸甲酯为原料,经环合、氯代和取代等反应得到6种新型喹唑啉类化合物,总收率为45%左右;目标产物结构经GC-MS和核磁~1HNMR进行表征.与传统方法相比,该法具有原料廉价易得、路线简短、操作简便和反应条件温和等优点,为后续的生物活性测试打下良好的基础. Six novel quinazolines were synthesized by the reaction of 2-amino-4-methoxy-3-( 3-chloropropoxy) benzoic acid methyl ester by cyclization,chlorination and substitution. The total yield was about 45%. The structure of target products was characterized by GC-MS and ~1HNMR. Compared with the traditional method,the method has the advantages of cheap raw materials,short route,easy operation and mild reaction conditions,which laid a good foundation for the subsequent bioactivity test.
作者 孟令强 杨绍娟 张小博 MENG Lingqiang;YANG Shaojuan;ZHANG Xiaobo(The Dean’s Office,Yanching Institute of Technology,Sanhe 065201,Hebei;School of Life and Health,Yanching Institute of Technology,Sanhe 065201,Hebei;College of Engineering,Yanching Institute of Technology,Sanhe 065201,Hebei)
出处 《四川师范大学学报(自然科学版)》 CAS 北大核心 2020年第3期357-363,共7页 Journal of Sichuan Normal University(Natural Science)
基金 廊坊市科技支撑计划(2017011070)。
关键词 2-氨基-4-甲氧基-3-(3-氯丙氧基)苯甲酸甲酯 合成 新型喹唑啉类化合物 2-amino-4-methoxy-3-(3-chloropropoxy) benzoic acid methyl ester synthesis novel quinazoline compounds
  • 相关文献

参考文献5

二级参考文献27

  • 1庞素华,郭宗儒.酪氨酸蛋白激酶抑制剂的研究进展[J].药学学报,1996,31(1):75-80. 被引量:8
  • 2Levin M,D’Souza N,Castaner J.Iressa oncolytic EGF receptor tyrosine kinase inhibitor[J].Drugs Fut,2002,27(4):339—345.
  • 3Zeneca Ltd.Quinazoline derivatives[P].EP:0566226,1993—10—20.
  • 4Zeneca Ltd.Qulnazoline derivatives[P].WO:19%/33980,1996—10—31.
  • 5Yarden Y, Sliwkowski MX. Untangling the erbB signaling network. Nat Rev Mol Cell Biol,2001,2(2):127-137.
  • 6Moniola AO, Neve RM, Lane HA, et al. The erbB signaling network: receptor heterdimerization in development and cancer.EMBO J, 2000,19(13):3159-3167.
  • 7Karashima T, Sweeney P, Slaton JW, et al. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice. Clin Cancer Res,2002,8(5) :1253-1264.
  • 8Xiong HQ, Abbruzzese JL. Epidemal growth factor receptor-targeted therapy for pancreatic cancer. Semin Oncol, 2002,29 (5 Suppl14):31-37.
  • 9Prewett MC, Hooper AT, Bassi R, et al. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against with human colorectal tumor xenografts. Clin Cancer Res, 2002,8(5):994-1003.
  • 10Yang XD, Jia XC, Corvalan JR, et al. Development of ABX-EGF,a fully human anti-EGF receptor monoclonal antibody, for cancer therapy. Crit Rev Oncol Hematol,2001,38(1):17-23.

共引文献27

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部